当前位置: X-MOL 学术Nat. Microbiol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Emerging antiviral resistance.
Nature Microbiology ( IF 20.5 ) Pub Date : 2020-01-01 , DOI: 10.1038/s41564-019-0639-7
Karen A Kormuth 1 , Seema S Lakdawala 2, 3
Affiliation  

Baloxavir marboxil (BXM) represents a promising advance in antiviral chemotherapies for influenza infections. Identification of transmissible BXM-resistant strains in Japan may hit pause on widespread adoption of this therapy and could lead to revision of surveillance practices for emerging viruses.

中文翻译:

新出现的抗病毒耐药性。

Baloxavir marboxil (BXM) 代表了流感感染抗病毒化疗的一个有希望的进展。在日本鉴定可传播的 BXM 抗性菌株可能会暂停该疗法的广泛采用,并可能导致对新兴病毒的监测实践进行修订。
更新日期:2019-12-19
down
wechat
bug